insights from industryShanoo BudhdeoDirector of Pharmaceutical ScienceSeda Pharmaceutical Development Services In this interview, NewsMedical speaks with Shanoo about her career progression and role ...
Siddhant Sojitra, Alexion, defines in an AAPS PharmSci 360 2025 presentation an agitation model to reliably test stability for early-stage biologics.
Global harmonization of CMC guidelines is a key focus for top pharmaceutical consultants. Variations in regulatory requirements across regions often create inefficiencies in drug development—for ...
“Metaverse” is no longer a mere buzzword. Many industries are discovering and developing applications for the Metaverse, and the pharma and biotech industry is no different. The many ways the ...
New drug development is a race against the clock as soon as the first patents are filed, and understanding the potential timings from first-in-human studies to regulatory approval is crucial for ...
On October 29, 2025, the FDA released a new draft guidance “Scientific Considerations in Demonstrating Biosimilarity to a Reference ...
There are three obstacles to faster development and deployment of non-addictive pain treatments. They are the business ...
The Food and Drug Administration (FDA) is launching an effort to streamline the approval process for cheaper alternative ...
MISSISSAUGA, Canada--(BUSINESS WIRE)--Eurofins CDMO Alphora Inc., a global Contract Development & Manufacturing Organization and part of the international network of Eurofins laboratories, is pleased ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation neuroplastogenic small molecules to address ...
The US Food and Drug Administration said Tuesday that Dr. Richard Pazdur has been named head of the Center for Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback